Other Events ·
The Court of Milan revoked a preliminary order that had suspended the effectiveness of an amendment to the Company's…
GNTAGenenta Science S.p.A.
The Court of Milan revoked a preliminary order that had suspended the effectiveness of an amendment to the Company's corporate purpose in Article 4 of its bylaws. This ruling, notified to the Company on July 13, 2026, restores the amendment's effectiveness, citing the Company's strategic interest in avoiding a strategic impasse. The underlying civil action challenging the validity of the shareholder resolutions remains pending. Genenta Science S.p.A. is a biotechnology company focused on developing therapeutic solutions.